33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135693
178559
2
Public Timelines
FAQ Obtener premium

28 sept 2017 año - FDA sent letters to IR opioid analgesic manufacturers informing them that their products that are intended to be used in the outpatient setting will be subject to the same REMS requirements as the ER/LA opioid analgesics.

Añadido al timeline:

13 nov 2018
0
0
520

fecha:

28 sept 2017 año
Ahora mismo
~ 8 years ago